Yue Hui Su
Directeur/Membre du Conseil chez MAKALOT INDUSTRIAL CO., LTD.
Profil
Yue Hui Su is currently serving as an Independent Director at Makalot Industrial Co., Ltd., In Win Development, Inc., CECI Engineering Consultants, Inc., Ennoconn Corp., Formosa Pharmaceuticals, Inc., and Soochow University as a Professor in the Accounting Department.
Previously, Dr. Su held positions as an Independent Director at TWi Pharmaceuticals, Inc., a Member of the Supervisory Board at Bank of Kaohsiung Co., Ltd., and a Professor in the Accounting Department at Soochow University.
Dr. Su completed their undergraduate, graduate, and doctorate degrees at National Taiwan University.
Postes actifs de Yue Hui Su
Sociétés | Poste | Début |
---|---|---|
MAKALOT INDUSTRIAL CO., LTD. | Directeur/Membre du Conseil | 21/02/2011 |
IN WIN DEVELOPMENT INC. | Directeur/Membre du Conseil | 01/07/2015 |
ENNOCONN CORPORATION | Directeur/Membre du Conseil | - |
FORMOSA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/07/2021 |
CECI Engineering Consultants, Inc. | Directeur/Membre du Conseil | - |
Soochow University /Taiwan/ | Corporate Officer/Principal | - |
Anciens postes connus de Yue Hui Su
Sociétés | Poste | Fin |
---|---|---|
TWI PHARMACEUTICALS INC | Directeur/Membre du Conseil | - |
Soochow University | Corporate Officer/Principal | - |
BANK OF KAOHSIUNG CO., LTD. | Directeur/Membre du Conseil | - |
Formation de Yue Hui Su
National Taiwan University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
MAKALOT INDUSTRIAL CO., LTD. | Consumer Non-Durables |
BANK OF KAOHSIUNG CO., LTD. | Finance |
IN WIN DEVELOPMENT INC. | Electronic Technology |
ENNOCONN CORPORATION | Electronic Technology |
FORMOSA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
CECI Engineering Consultants, Inc. | |
TWi Pharmaceuticals, Inc.
TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |